Tipp

Notes on breast cancer prevention and screening

Zeitschrift:: memo - Magazine of European Medical Oncology > Ausgabe 3/2015

Autor:: MD Dr. med. Dr. rer. nat. Hans-Peter Köst

» Jetzt Zugang zum Volltext erhalten

Without Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Jetzt informieren

Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto: Canadian Cancer Society; 2014, p. 8, 132, ISSN 0835–2976.

American Cancer Society. Cancer Facts & Figs. 2014. Atlanta: American Cancer Society; 2014. p 68.

Amtliche Todesursachenstatistik, Wiesbaden. Statistisches Bundesamt. Gesundheit. Todesursachen in Deutschland, Fachserie 12 Reihe 4. Wiesbaden: Statistisches Bundesamt; 2013. p 53.

Krebs in Deutschland. 2009/2010. Robert Koch-Institut, Herausgeber und die Gesellschaft der epidemiologischen, 9. Ausgabe. Berlin: Krebsregister in Deutschland e.V, Herausgeber; 2013. pp. 16–17.

Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T, The American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. American cancer society guidelines on nutrition and physical activity for cancer prevention. Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62:30–67. CrossRefPubMed

World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 2007.

Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004;39:155–65. (Review) CrossRefPubMed

Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 2013; 346:f385. doi:10.1136/bmj.f385. CrossRefPubMed

Norat T, Chan D, Lau R, Vieira R. The associations between food, nutrition and physical activity and the risk of breast cancer. WCRF/AICR systematic literature review continuous update project report. London: World Cancer Research Fund/American Institute for Cancer Research; 2008.

10.

Tomasetti C, Vogelstein B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347:78–81. CrossRefPubMed

11.

American Cancer Society. Breast cancer facts & figures 2013–2014. Atlanta: American Cancer Society, Inc. 2013.

12.

Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. BJC. 2013;108:2205–40. doi:10. 1038/bjc.2013.177. PubMedCentralCrossRefPubMed

13.

Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366. doi:10.1 136/bmj.g366. PubMedCentralCrossRefPubMed

14.

Parvinen I, Heinävaara S, Anttila A, Helenius H, Klemi P, Pylkkänen L. Mammography screening in three Finnish residential areas: comprehensive population- based study of breast cancer incidence and incidence-based mortality 1976–2009.Br J Cancer. 2013;108:2205–40. doi:10.1038/bjc.2013.177. CrossRef

15.

National Cancer Institute: Breast Cancer Screening (PDQ®). Bethesda, MD: National Cancer Institute. Date last modified 06/19/2015. Available at: http://www.cancer.gov/types/breast/hp/breast-screening-pdq. Accessed June 25, 2015

16.

Moss S. Over-diagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005;7:230–4. PubMedCentralCrossRefPubMed

17.

Welch HG. Over-diagnosis and mammography screening. BMJ. 2009;339:182–3. CrossRef

18.

Elmore JG, Harris RP. The harms and benefits of modern screening mammography. BMJ. 2014;348:g3824. doi:10.1136/bmj.g3824. CrossRefPubMed

Titel: Notes on breast cancer prevention and screening
Autor:: MD Dr. med. Dr. rer. nat. Hans-Peter Köst
Publikationsdatum: 01.09.2015
DOI: https://doi.org/10.1007/s12254-015-0218-4
Verlag: Springer Vienna
Zeitschrift: memo - Magazine of European Medical Oncology An International Journal for Oncology and Haematology Professionals
Ausgabe 3/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Without Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Weitere Artikel der Ausgabe 3/2015

ASH 2014 update: Myelodysplastic syndromes and acute myeloid leukemia

Highlights of the American Society of Hematology Meeting 2014: Hemostaseology

Indolent lymphoma at ASH 2014: new kids on the block (iDrugs)

ASH 2014: novel strategies in the management of classical Hodgkin’s lymphoma

Prognostic factors and their correlation with staging in patients with multiple myeloma: a single centre study in North India

A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years